Physician profile
Toby C Silvertooth
NPI 1144771288
$1,871.58
in general payments reported to CMS, 2019-2025
19 companies · $321 in 2025
The $321 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.50 · 2022: $115 · 2023: $705 · 2024: $710 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $341.68 | 2023-2025 | Krystexxa, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $329.15 | 2022-2025 | Lifevest |
| Abbott Laboratories | $231.87 | 2023-2025 | Mitraclip |
| Merck Sharp & Dohme LLC | $141.57 | 2022-2024 | Verquvo |
| Heartflow, INC. | $136.55 | 2023 | Ffrct |
| Abbvie INC. | $123.95 | 2024 | |
| Medtronic, INC. | $118.94 | 2024 | Corevalve Evolut R, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $93.87 | 2025 | |
| Gilead Sciences, INC. | $72.94 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $66.83 | 2023 | Camzyos |
| Irhythm Technologies, INC. | $40.11 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $38.46 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.13 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.90 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.56 | 2023 | Jardiance |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $18.70 | 2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $16.84 | 2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $14.89 | 2024 | |
| Pfizer INC. | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toby Silvertooth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.